Medigen Vaccine Biologics CO.(MVC)’s vaccine plant successfully granted the building occupancy permit read more
Medigen Vaccine Biologics CO. attended Stock Investment Forum hosted by Sinopac Securities Investment Trust Co. read more
Medigen Vaccine Biologics CO. received 14.03 million TWD funding from Ministry of Economic Affairs for H7N9 Phase I/II clinical trial read more
Medigen Vaccine Biologics CO. issued 20,000,000 new shares of the common stock for seasoned equity offering read more
Wealth Magazine apologized for the misleading report on Medigen’s PI-88 new drug development. Accordingly, Medigen agreed to withdraw the complaints against Wealth Magazine. read more
Medigen Vaccine Biologics Co. listed on Taiwan OTC stock market (emerging stock market) on Aug 6th, 2015. read more
Medigen Vaccine Biologics Co. listed on Taiwan OTC stock market (emerging stock market) on Aug 6th, 2015. read more